Your browser doesn't support javascript.
loading
Conceptual Framework for Patient-Reported Outcome Measures in Clinical Trials of Skeletal Muscle Cramping Experienced in Dialysis: A Kidney Health Initiative Workgroup Report.
Richardson, Michelle M; Grandinetti, Amanda; Hilliard-Boone, Tandrea S; Wilund, Kenneth R; Wingard, Rebecca; St Peter, Wendy L; Logan, Dilani; Tentori, Francesca; Keller, San; West, Melissa; Lacson, Eduardo.
Afiliación
  • Richardson MM; William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
  • Grandinetti A; Dialysis Clinic, Inc., Nashville, Tennessee.
  • Hilliard-Boone TS; Kidney Health Initiative Patient and Family Partnership Council, Kidney Health Initiative, Washington, DC.
  • Wilund KR; American Institutes for Research, Health, Chapel Hill, North Carolina.
  • Wingard R; Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Champaign, Illinois.
  • St Peter WL; Fresenius Medical Care North America Clinical Services, Waltham, Massachusetts.
  • Logan D; College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.
  • Tentori F; American Institutes for Research, Health, Oakland, California.
  • Keller S; DaVita Clinical Research, Minneapolis, Minnesota.
  • West M; American Institutes for Research, Health, Chapel Hill, North Carolina.
  • Lacson E; American Society of Nephrology, Washington, DC.
Clin J Am Soc Nephrol ; 17(10): 1563-1574, 2022 10.
Article en En | MEDLINE | ID: mdl-35292531
ABSTRACT
Skeletal muscle cramping is a common and bothersome symptom for patients on maintenance dialysis therapy, regardless of modality, and it has not been prioritized for innovative assessments or treatments. Research to prevent or treat skeletal muscle cramping in patients receiving dialysis is hindered by poorly understood pathophysiology, lack of an accepted definition, and the absence of a standardized measurement method. The Kidney Health Initiative, a public-private partnership between the American Society of Nephrology and US Food and Drug Administration, convened a multidisciplinary workgroup to define a set of patient-reported outcome measures for use in clinical trials to test the effect of new dialysis devices, new KRTs, lifestyle/behavioral modifications, and medications on skeletal muscle cramping. Upon determining that foundational work was necessary, the workgroup undertook a multistep process to elicit concepts central to developing the basis for demonstrating content validity of candidate patient-reported outcome measures for skeletal muscle cramping in patients on dialysis. The workgroup sought to (1) create an accepted, patient-endorsed definition for skeletal muscle cramping that applies to all dialysis modalities, (2) construct a conceptual model for developing and evaluating a skeletal muscle cramping-specific patient-reported outcome measure, and (3) identify potential questions from existing patient-reported outcome measures that could be modified or adapted and subsequently tested in the dialysis population. We report the results of the workgroup's efforts, provide our recommendations, and issue a call to action to address the gaps in knowledge and research needs we identified. These action steps are urgently needed to quantify skeletal muscle cramping burden, assess the effect, and measure meaningful changes of new interventions to improve the experience of patients receiving dialysis and suffering from skeletal muscle cramping.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diálisis Renal / Fallo Renal Crónico Tipo de estudio: Guideline Idioma: En Revista: Clin J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diálisis Renal / Fallo Renal Crónico Tipo de estudio: Guideline Idioma: En Revista: Clin J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2022 Tipo del documento: Article